Video: AZ’s Brennan on Manufacturing as a Core Competency

AstraZeneca raised some eyebrows a few years ago when executives suggested that the company would outsource most of its manufacturing operations. In this interview, CEO David Brennan clarifies this perception: It’s all about recognizing your core competencies, he says, and for AZ that means biologics and late-stage small molecule production. For “commodity” operations, outsourcing makes perfect sense, he says.